Switching to Faricimab in Neovascular Age-related Macular Degeneration Resistant to Both Aflibercept and Ranibizumab

Name: Switching to Faricimab in Neovascular Age-related Macular Degeneration Resistant to Both Aflibercept and Ranibizumab
License: Public Domain

Rigshospitalet, Denmark

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

neovascular age-related macular degeneration

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174921
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.